Abstract
Background
The fate of the contralateral unaffected side of the surgically treated unilateral moyamoya disease (MMD) in adults has not been well described due to the limited number of cases and the heterogeneous ages and treatment methods. The aim of this study was to evaluate the contralateral angiographic progression rate and its risk factors in homogeneous adult MMD patients who underwent surgical revascularization, with a review of pertinent literature.
Methods
Forty-one surgically treated unilateral MMD patients were retrospectively evaluated. We reviewed medical and radiological records including data on gender, age, hypertension (HTN), smoking, familial MMD, presenting symptom, surgical method, Suzuki stage, and contralateral progression. Then, we conducted univariate and multivariate analyses to determine risk factors.
Results
Six of the 41 cases (14.6 %) exhibited contralateral progression during the mean follow-up of 34 months. Four of those six patients (66.7 %) were asymptomatic. Additional revascularization surgery was performed in the two symptomatic patients. The presence of a contralateral angiographic abnormality on initial angiography was a statistically significant risk factor for progression (OR, 49.00; p = 0.04). Younger age at diagnosis (32.7 ± 7.8 years in progression group vs. 42.5 ± 10.3 years in non-progression group, p = 0.046) was statistically significant in the univariate analysis, but age was not a significant factor in the multivariate analysis (p = 0.82). Other variables, such as gender (p = 0.13), HTN (p = 0.24), smoking (p = 0.47), and familial MMD (p = 0.20), did not show statistical significance.
Conclusions
The presence of a contralateral angiographic abnormality on initial angiography was a significant risk factor for progression in surgically treated unilateral adult MMD. Consequently, patients with contralateral abnormalities should be monitored closely.
Similar content being viewed by others
References
Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99(Suppl 2):S238–S240
Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT 3rd, Zipfel GJ, Dacey RG Jr, Derdeyn CP (2006) Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37:1490–1496
Hayashi K, Suyama K, Nagata I (2010) Clinical features of unilateral moyamoya disease. Neurol Med Chir (Tokyo) 50:378–385
Hirotsune N, Meguro T, Kawada S, Nakashima H, Ohmoto T (1997) Long-term follow-up study of patients with unilateral moyamoya disease. Clin Neurol Neurosurg 99(Suppl 2):S178–S181
Houkin K, Abe H, Yoshimoto T, Takahashi A (1996) Is “unilateral” moyamoya disease different from moyamoya disease? J Neurosurg 85:772–776
Jeon JS, Sheen SH, Hwang GJ, Kim HC, Kwon BJ (2013) Feasibility of intravenous flat panel detector CT angiography for intracranial arterial stenosis. AJNR Am J Neuroradiol 34:129–134
Kaku Y, Morioka M, Ohmori Y, Kawano T, Kai Y, Fukuoka H, Hirai T, Yamashita Y, Kuratsu J (2012) Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) 154:2151–2157
Kawano T, Fukui M, Hashimoto N, Yonekawa Y (1994) Follow-up study of patients with “unilateral” moyamoya disease. Neurol Med Chir (Tokyo) 34:744–747
Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK (2006) Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis 22:109–115
Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC (2010) Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 68:92–101
Kim JE, Kim KM, Kim JG, Kang HS, Bang JS, Son YJ, Han MH, Oh CW (2012) Clinical features of adult moyamoya disease with special reference to the diagnosis. Neurol Med Chir (Tokyo) 52:311–317
Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC (2004) Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54:840–844, discussion 844–846
Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y (2005) Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36:2148–2153
Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K (1992) Surgical treatment of moyamoya disease in pediatric patients–comparison between the results of indirect and direct revascularization procedures. Neurosurgery 31:401–405
Matsushima Y, Aoyagi M, Suzuki R, Nariai T, Hirakawa K (1994) Entity of unilateral moyamoya disease and indication of indirect anastomosis for ‘unilateral moyamoya disease.’ In: Fukui M (ed.) Proceedings of the Research Committee on Spontaneous Occlusion of the Circle of Willis. Ministry of Health and Welfare, Tokyo, Japan, pp 57–64
Ogata T, Yasaka M, Inoue T, Yasumori K, Ibayashi S, Iida M, Okada Y (2008) The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease? Cerebrovasc Dis 26:244–249
Park EK, Lee YH, Shim KW, Choi JU, Kim DS (2011) Natural history and progression factors of unilateral moyamoya disease in pediatric patients. Childs Nerv Syst 27:1281–1287
Patel NN, Mangano FT, Klimo P Jr (2010) Indirect revascularization techniques for treating moyamoya disease. Neurosurg Clin N Am 21:553–563
Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI (2000) A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21:643–646
Sawada T, Yamamoto A, Miki Y, Kikuta K, Okada T, Kanagaki M, Kasahara S, Miyamoto S, Takahashi JC, Fukuyama H, Togashi K (2012) Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels. Neuroradiology 54:1089–1097
Sueishi K, Kono S (1993) Immunohistochemical localization of basic fibroblast growth factor in the narrowed arteries of the arteries of Willis in moyamoya disease. In: Fukui H (ed) 1992 Proceedings of the Research Committee on Spontaneous Occlusion of the Circle of Willis [in Japanese]. Ministry of Health and Welfare Japan, Tokyo, Japan, pp 131–133
Smith ER, Scott RM (2008) Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 24:E17
Tanaka M, Sakaguchi M, Kitagawa K (2012) Mechanism of moyamoya vessels secondary to intracranial atherosclerotic disease: angiographic findings in patients with middle cerebral artery occlusion. J Stroke Cerebrovasc Dis 21:373–378
Wong KS, Lam WW, Liang E, Huang YN, Chan YL, Kay R (1996) Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Stroke 27:1084–1087
Yao B, Li TQ, Gelderen P, Shmueli K, de Zwart JA, Duyn JH (2009) Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 44:1259–1266
Yeon JY, Shin HJ, Kong DS, Seol HJ, Kim JS, Hong SC, Park K (2011) The prediction of contralateral progression in children and adolescents with unilateral moyamoya disease. Stroke 42:2973–2976
Acknowledgments
We would like to thank Sung-Eun Kim for help with data collection and for valuable contributions to the statistical analysis.
Disclosure of funding
None to disclose.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Sang Chul Lee and Young Seob Chung contributed equally to this work.
Rights and permissions
About this article
Cite this article
Lee, S.C., Jeon, J.S., Kim, J.E. et al. Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature. Acta Neurochir 156, 103–111 (2014). https://doi.org/10.1007/s00701-013-1921-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-013-1921-8